Free Daily Podcast Summary
Galaxy Balance: Daily Summaries Delivered
by Cory Smith
Galaxy Balance explores the frontier where biology, technology and consciousness meet. Each episode brings together pioneers shaping our collective future, from genome engineers and AI builders to longevity researchers, space explorers, and mindfulness practitioners. Hosted by Cory Smith, the conversations dive deep into how these seemingly distant fields form an interconnected ecosystem, one that balance innovation with introspection, science with spirit, and ambition with awareness. At its core, Galaxy Balance is about integration; the idea that our greatest leaps forward happen when disciplines collide. The same algorithms that decode galaxies can help us understand genomes; the same principles that govern consciousness can illuminate AI. Through long-form, unscripted dialogue, the show invites listeners to zoom out from the silos of specialization and see the larger pattern: a living system of intelligence evolving across scales – molecular, planetary, and cosmic.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 1 weeks ago1h 7m
Humanity May Become the Little Green Men
If the universe contains billions of potentially habitable worlds, where is everybody?Dr. Terry Adair, author of Where Are the Little Green Men? The Adair Hypothesis, joins Galaxy Balance to examine the Fermi paradox through the lens of energy. His hypothesis proposes that an advanced technological civilization requires access to an abundant, dense, storable, transportable, and scalable energy supply.The conversation traces Earth’s energetic evolution from hydrothermal chemistry and photosynthesis to fire, fossil fuels, nuclear fission, and fusion. Terry explains how photosynthesis enabled complex life while also creating the ancient reserves of coal, oil, and natural gas that eventually powered industrial civilization. He argues that this unlikely sequence may represent a series of filters preventing intelligent life elsewhere from producing detectable technology or reaching other stars.We also explore the Drake equation, abiogenesis, the evolution of complex life, the technological limitations of ocean worlds, the challenges surrounding red dwarf stars, and the laws of thermodynamics that constrain every possible civilization. Terry outlines how fusion energy could eventually enable plasma drives, antimatter production, and spacecraft capable of reaching a meaningful fraction of the speed of light.The episode closes with an optimistic vision of humanity’s long-term future. If we continue expanding our scientific knowledge and energy capabilities, humans may eventually become the interstellar visitors that other civilizations look toward the sky hoping to find.00:00 - Why the Fermi paradox belongs at the center of this conversation03:37 - How Adair’s background led him to an energy-based hypothesis04:20 - What the Fermi paradox actually means08:14 - Drake equation, exoplanets, and the Great Filter10:23 - Why the Drake equation is a framework, not an exact answer11:47 - Why abiogenesis and intelligence are not the same question13:29 - Earth’s evolutionary milestones from microbes to technology15:10 - Why photosynthesis is the breaking point in life’s history18:28 - The difference between abundant energy and usable energy21:49 - Endosymbiosis, mitochondria, and the energy jump in complex life23:51 - Why CO2 is the raw material behind plant structure26:19 - How biomass became coal, oil, and natural gas29:25 - Where uranium and thorium come from31:46 - Why nuclear fusion is central to future civilization33:34 - Entropy, disorder, and why perpetual motion fails38:03 - The limits of fossil fuels and the case for nuclear fission40:02 - Weapons, waste, and why small modular reactors matter43:20 - The Adair Hypothesis, defined44:14 - Fire as humanity’s first technology47:27 - The photosynthetic trap and why fossil fuels changed civilization49:58 - How much energy humanity has burned in 200 years51:21 - Could an aquatic species build technology without fire?52:32 - From Democritus to quarks: what matter really is56:22 - Why energy access on Earth is still an equity issue58:51 - Antimatter, plasma drives, and propulsion limits62:47 - Why fusion-powered travel is a 300 to 400 year project64:21 - Humans as the future “little green men”65:21 - Why Star Wars is Adair’s favorite science fiction reference
- 3 weeks ago1h 3m
Can We Make a Drug for One Person?
What if we could design a medicine for a single person?Casey McPherson was a musician and songwriter when his daughter Rose was diagnosed with an ultra-rare neurogenetic disease. There was no approved treatment and no clear path forward. Rather than accepting that answer, Casey began learning genetics, building a network of scientists, and ultimately creating the infrastructure needed to develop a treatment for his daughter.Today, Casey is the CEO and co-founder of Alpha Rose Therapeutics, where his team is working to make individualized genetic medicine scalable. Their approach combines antisense oligonucleotides, patient-derived stem cells, AI-guided therapeutic design, automation, and a new economic model for diseases that traditional drug development often leaves behind.We discuss how Alpha Rose reduced a therapeutic amenability analysis that once took months to just minutes using AI, why Casey believes drug development should eventually be approved as a repeatable process rather than one drug at a time, and how point-of-care synthesis could allow personalized genetic medicines to be produced rapidly for individual patients.We also explore autonomous laboratories, AI scientists, patient-derived iPSCs and brain organoids, the economics of rare disease, genetic enhancement, and a future of medicine that looks increasingly like the sick bay of Star Trek: understand the unique biology of the patient, design the intervention, synthesize it, and treat them.Casey's story raises a much bigger question. Are rare diseases really rare, or are they the first glimpse of a future where every disease becomes individualized? 00:00 - Casey McPherson’s path from musician to biotech founder01:38 - Childhood curiosity: music, programming, electronics, and biology04:16 - Rose’s diagnosis and the end of the traditional care pathway07:46 - Learning the problem was bigger than one child09:59 - Why a foundation and ecosystem had to come first11:27 - Why Rare Labs was built as a modality agnostic discovery lab12:24 - Why antisense oligonucleotides made sense for Rose13:22 - Designing and filtering thousands of ASO candidates15:13 - Building patient-specific iPSCs and brain organoids17:25 - Why animal models are mainly a safety tool20:06 - Why Alpha Rose became a public benefit corporation23:22 - Regulatory strategy and the path toward a small patient trial27:35 - How Casey learned drug development by doing30:30 - The AI amenability study workflow for new patients33:24 - Turning a rough AI prototype into a validated internal tool35:34 - Using the tool on every new drug and patient case36:31 - Why speed matters when families are waiting on treatment37:54 - Rare disease as a business model problem, not just a science problem43:02 - The next decade of individualized medicine44:27 - Process approval and point-of-care drug synthesis46:34 - Beyond rare disease: enhancement and broader applications48:24 - Why children’s health is so underfunded51:20 - Why precision medicines can lower development risk53:33 - Robotics and the fully automated lab of the future55:46 - Renee, conversational AI, and the scientist-as-assistant future56:54 - Science fiction influence and the Star Trek medicine model59:50 - Advice for families and scientists facing genetic disease1:02:21 - Closing thoughts on individualized disease
- Aug 10, 20261h 6m
Clarice Aiello: The Hidden Quantum Physics of Biology
Could life be using quantum physics to sense the world, regulate cellular processes, and respond to magnetic fields?Clarice Aiello is a quantum engineer, Chair of the Board and Chief Scientific Officer at the Quantum Biology Institute, and the founder of the former Quantum Biology Tech Lab at UCLA. Her research explores whether living systems harness quantum phenomena once considered too fragile to survive within warm, noisy cells.In this episode of Galaxy Balance, Clarice explains quantum tunneling, superposition, entanglement, and decoherence through the lens of biology. We discuss how electrons inside proteins may function as nature-made quantum sensors, how weak magnetic fields can influence cellular behavior, and whether engineered magnetic fields could eventually support wound healing, regeneration, and other forms of electromagnetic medicine.Clarice also describes the evidence that birds may use quantum sensing to navigate, why nature could teach us to build better quantum technologies, and how altered magnetic environments may affect organisms traveling to the Moon or Mars. We explore the scientific standards needed to move quantum biology into the mainstream, the limits of current evidence, and the possibility of creating a Star Trek-style tricorder that interacts with biology through precisely designed magnetic fields.The conversation closes with quantum literacy, science fiction, interdisciplinary research, and Clarice’s advice for the next generation of scientists entering one of biology’s strangest emerging frontiers.0:00 Clarice Aiello’s background and why quantum biology matters7:12 The long-term vision for magnetic-field-based therapeutics10:30 Why the field still lacks depth, breadth, and standards15:30 What quantum physics is, in plain language19:01 Superposition explained with dimmer-switch logic26:19 Why decoherence limits quantum effects in warm, wet cells29:27 What counts as evidence for quantum biology today32:24 Skepticism about entanglement, microtubules, and consciousness claims34:37 The double-slit experiment and why observation is often misunderstood37:11 Mars, the Moon, and why magnetic fields may matter for colonization41:37 How weak magnetic fields may work at the protein level44:36 Spin-dependent chemical reactions and biological branching53:14 Why Clarice thinks nature is effectively a quantum engineer58:13 Science fiction, Recursion, and what it gets right and wrong about observation59:05 Why quantum literacy should be part of basic education
- Jul 27, 202657 min
Li Li: Rewiring Skin Aging With AI and mRNA
00:00 - Introduction to Lily and GLife’s vision for data-driven dermatology01:20 - Lily’s scientific background 02:43 - Breakthroughs from single-cell atlases03:50 - The motivation behind founding GLife 04:50 - The importance of treating skin as a foundational organ 05:48 - Discovery of key molecular drivers of aging 06:22 - Challenges of fundraising07:45 - The novel approach to rejuvenating hair loss through targeted messenger RNA treatments08:53 - How treatments will be delivered via microneedles and micro patches09:32 - The potential to alter hair color and explore cosmetic applications10:06 - Balancing platform discovery engines with the development of first-in-class therapeutics10:43 - The comprehensiveness of the skin atlas and addressing genetic diversity11:39 - Technical challenges of capturing skin’s cellular heterogeneity and stem cell populations12:50 - The importance of isoforms and deep sequencing in understanding gene functions13:16 - Short-lived messenger RNA as a safe, reversible treatment modality14:55 - Safety considerations and toxicity management 16:01 - Biodistribution studies and local micro-needle delivery safety17:00 - Next steps towards clinical trials and regenerative therapies for hair loss18:08 - The role of big data and omics in understanding skin disorders and aging19:04 - The significance of isoforms in skin biology and gene function20:13 - Endogenous vs. modified messenger design for safety and efficacy21:32 - Potential for multi-gene delivery to enhance hair regrowth and color restoration22:22 - Conception of patches that work with existing hair without shaving23:38 - Targeting broad hair loss types and the concept of root causes24:47 - Modeling hair loss with animal models and regulatory considerations25:48 - Regulatory perspectives on non-animal models and validation strategies26:34 - The interplay between genetic and environmental causes of skin aging27:54 - The biological hub role of specific transcription factors in stress and aging29:10 - The future of skin biomarkers for diagnosis and personalized health monitoring30:18 - Leveraging AI’s data integration and precision medicine in dermatology32:32 - The impact of protein isoforms and post-translational modifications in skin treatment34:47 - Interest in peptides, small molecules, and biohacking trends for skin health36:03 - Collaboration between wet labs, computational teams, and clinical partners36:36 - The significance of internal naming conventions in research and development37:28 - The high-throughput screening process for key transcription factors38:13 - Strategies for overexpressing target genes in therapeutic design39:00 - AI’s role in accelerating discovery and development pipelines in biotech40:39 - Addressing data quality, heterogeneity, and integration challenges in big datasets44:12 - Envisioning personalized skincare driven by genomics and AI44:56 - The inspiring concept that ancient technologies now seem like magic45:24 - Challenges in bringing novel dermatological treatments through trials and regulation47:42 - The evolving role of AI in drug quality control and documentation48:11 - Unique advantages of Lily’s targeted mRNA approach over other modalities49:22 - Using skin as a model system for broader human biology insights50:28 - Perspectives on epigenetic reprogramming and cellular re-differentiation51:22 - Fundraising experiences and strategic positioning for biotech development52:21 - The influence of science fiction, especially “Three Body Problem” and “Interstellar,” on Lily’s vision54:24 - Advice to young scientists: read widely, think deeply, and dream big
- Jul 13, 20261h 3m
Aditya Kunjapur: Bringing New Chemistry to Life
What does it take to bring new chemistry to life?In this episode of Galaxy Balance, Cory Smith speaks with Aditya Kunjapur, Associate Professor of Chemical and Biomolecular Engineering at the University of Delaware, about genetic code expansion, non-standard amino acids, engineered microbes, and the future of synthetic biology.Aditya’s lab explores how biology can be programmed to biosynthesize chemical groups that are rare or absent in nature, install those new building blocks into proteins, and make microbial survival depend on synthetic chemistry. The conversation moves from his early path through energy and chemical engineering, to his time in George Church’s lab, to the founding of Nitro Biosciences and the use of expanded genetic codes for next generation vaccine platforms.They discuss how non-standard amino acids can act as chemical flags for the immune system, how live microbes could produce antigens inside the body, and why genetic code expansion may open new approaches to vaccines, biocontainment, agriculture, environmental engineering, and planetary protection.The episode also explores synthetic auxotrophy, engineered microbial dependence, plant controlled microbial survival, plastic degradation, agricultural probiotics, bioenergy, AI tools for non-standard amino acids, and the science fiction lessons behind containment, from Jurassic Park to modern AI.This is a conversation about rewriting the language of life, not only to understand biology, but to give it new chemistry, new safeguards, and new possibilities.Timestamps:00:00 - Engineering microbes for space: Bacillus subtilis and biological containment02:28 - Aditya’s pathway into synthetic biology and innovative chemistry05:46 - Transitioning from industry internships to academia and entrepreneurship10:16 - Founding Nitro Biosciences: balancing entrepreneurship with academic research16:31 - Genetic code expansion and its potential to elicit immune responses22:41 - The scarcity and potential of non-standard amino acids in life27:26 - Detecting extraterrestrial life and the shared building blocks of biology36:49 - Synthetic oxytrophy and microbial biocontainment strategies44:01 - Reducing herbicide reliance with engineered microbes in agriculture52:53 - Computational tools and AI for non-standard amino acid research54:53 - Bioenergy and sustainability: bio-catalysis innovations59:08 - How science fiction influences bioengineering and AI safety considerations
- Jun 29, 20261h 0m
Erik Aznauryan: Writing Genes at Scale
Erik Aznauryan, CEO and co-founder of HarborSite, joins Galaxy Balance to explore the next frontier of genome engineering: moving beyond small edits and toward precise, large-scale DNA insertion. Erik traces his path from Armenia and medical school to Europe, the Church Lab, and eventually founding HarborSite with a mission to make gene insertion safer, more durable, and more programmable.The conversation dives into recombinases, safe harbor sites, payload size limits, delivery vehicles, in vivo validation, AI-driven protein engineering, and the therapeutic promise of inserting full genes or even entire genetic programs into the genome. Cory and Erik also discuss rare disease, cell therapy, skin and liver targeting, regulatory bottlenecks, animal models, funding shifts in biotech, and the long-term possibility of human enhancement in an age of AI.At the edge of science fiction and translational medicine, this episode asks what becomes possible when genome engineering evolves from editing biology to writing biology at scale00:00 — The North Star for genome engineering00:36 — Introduction to Erik and HarborSite01:39 — Erik’s path into science02:36 — Early fascination with cloning and genome engineering03:21 — Cory’s own early inspiration04:03 — Why genome engineering matters05:24 — Ethical questions around germline engineering06:37 — Why early-stage intervention matters07:51 — Technical progress and disease-specific editing09:25 — Why HarborSite was founded10:50 — Recombinases as the core technology12:15 — Engineering recombinases for new DNA targets13:12 — Novel genomic safe harbors14:18 — How safe harbors are selected and validated15:36 — How much target specificity can be changed?16:36 — Why lifelong expression matters17:29 — Testing durability in culture and in vivo18:26 — The appeal of the albumin locus19:15 — Endogenous production of biologics20:59 — Startup challenges and fundraising22:28 — Why LabCentral is valuable23:07 — AI BioHub and large proprietary datasets24:08 — AI’s role in model development25:11 — Practical uses of AI in biotech startups26:51 — How the team handles data analysis27:56 — What the therapeutic product looks like28:52 — First target tissues: liver and T cells30:27 — Testing off-target integration31:27 — Balancing specificity and efficiency32:24 — Lessons from CAR-T and random integration33:40 — Why recombinase systems may be safer34:39 — Payload size and delivery constraints35:35 — Delivery strategies under consideration38:09 — Simpler donor DNA formats39:38 — Platform company and therapeutic company40:59 — The key milestone: in vivo validation41:48 — HarborSite’s pre-seed raise43:05 — How VC expectations have shifted44:26 — Choosing the right in vivo model46:22 — The continued importance of mouse studies48:23 — Global regulatory differences50:10 — Science funding in the U.S.52:40 — Synthetic biology in space54:34 — Enhancement and self-directed health57:40 — Science fiction and inspiration59:34 — Advice for young scientists60:31 — Closing remarks
- Jun 15, 20261h 7m
Intertwined Biosciences: Engineering Evolution for Human Health
Max Rye and Evan Appleton of Intertwined Bio join Galaxy Balance to explore one of the boldest ideas in modern biology: borrowing nature’s most extreme traits and translating them into human health.From horses that resist liver cirrhosis to naked mole rats, bowhead whales, radiation resistant organisms, hibernating animals, and the future of humans in space, this conversation asks what becomes possible when evolution itself becomes a design library. Max and Evan explain how Intertwined Bio is using synthetic biology, gene editing, AI, virtual macrophages, and agentic systems to identify traits from extraordinary animals and test whether those adaptations can be engineered into human cells.We discuss liver fibrosis, DNA damage repair, innate immune engineering, longevity, space radiation, de extinction, Colossal Biosciences, the future of virtual cells, and the ethical line between therapy and enhancement.This is a conversation about turning science fiction into biology.00:00 - Introduction to Intertwined Bio and their innovative approach01:01 - The origins and motivations of Max and Evan in biotech04:56 - Scientific foundation: Borrowing traits from long-lived and resilient animals07:16 - Why now? Recent technological advances enabling these innovations10:46 - Role of AI in understanding complex biological systems and virtual cell modeling14:17 - Delivery strategies for genetic modifications in humans18:19 - Regulatory pathways and ethical boundaries in gene editing22:25 - The potential of junk DNA variants and regulatory engineering27:09 - The potential impact on sports animals and broader applications31:12 - Industry landscape, collaboration, and competition33:21 - Building a startup: team dynamics, trust, and early steps35:58 - Insights on other biotech ventures like AstroMech and their directions38:39 - Space applications: radiation resistance, hibernation, and life support systems43:01 - Prioritizing targets using AI and high-throughput screening48:31 - Broader prospects: aging, longevity, and the OZEMPIC effect52:44 - Focus on innate immune system engineering and virtual cell development57:15 - Strategies for macrophage gene editing and cell type targeting1:01:36 - Bottlenecks in lab throughput and cell growth limitations1:04:30 - The influence of science fiction on biotech innovation and ethical outlooks1:06:14 - Closing thoughts: science fiction as inspiration and the rapid transition of ideas into reality
- Jun 1, 20261h 2m
Charles Fracchia: Securing the Bioeconomy
In this episode of Galaxy Balance, I sit down with Charles Fracchia to explore the emerging infrastructure layer of synthetic biology. We discuss the future of secure and scalable bioengineering, the role of community laboratories in accelerating innovation, and how biology is evolving into a programmable technology platform. Charles shares the story behind BioBright, the creation of Bio-ISAC, and the broader challenge of building resilient systems for a world where genetic engineering becomes increasingly accessible.The conversation moves from cyberbiosecurity and open science to AI-driven biological design, scientific culture, and the growing overlap between software engineering and biotechnology. We also explore the long-term future of human enhancement, decentralized science, and how science fiction continues to shape the ambitions of the next generation of builders working at the frontier of biology.Timestamps:00:00 - Overcoming cynicism in AI's role in biosecurity00:40 - Introduction to Charles Fracchia and his pioneering work02:07 - Charles's background and journey into biotech innovation04:01 - Balancing classical education with trial-by-fire experience06:26 - AI as a search tool versus experimental center in biology08:28 - Developing AI systems for biological experiment automation11:35 - The founding and evolution of Black Mesa and its mission14:26 - The importance of digital batch records and AI-assisted QA QC16:06 - AI's role in drug development, safety, and traceability18:44 - Ensuring trust and integrity in AI models for biotech applications22:51 - Addressing data poisoning and ensuring model robustness24:45 - Strategies for verifying biological data integrity through cryptography and blockchain33:55 - Future threats like AI-driven bio weapons and safeguarding strategies42:48 - The importance of operational innovation in accelerating bioeconomy growth58:25 - Influence of science fiction on biosecurity and innovation60:11 - Advice for emerging scientists in a rapidly changing landscape1:02:53 - Closing remarks and future outlook from Charles Fracchia
About Galaxy Balance
Galaxy Balance explores the frontier where biology, technology and consciousness meet. Each episode brings together pioneers shaping our collective future, from genome engineers and AI builders to longevity researchers, space explorers, and mindfulness practitioners. Hosted by Cory Smith, the conversations dive deep into how these seemingly distant fields form an interconnected ecosystem, one that balance innovation with introspection, science with spirit, and ambition with awareness. At its core, Galaxy Balance is about integration; the idea that our greatest leaps forward happen when disciplines collide. The same algorithms that decode galaxies can help us understand genomes; the same principles that govern consciousness can illuminate AI. Through long-form, unscripted dialogue, the show invites listeners to zoom out from the silos of specialization and see the larger pattern: a living system of intelligence evolving across scales – molecular, planetary, and cosmic.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Galaxy Balance in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Galaxy Balance daily summary?
It's a free AI-powered email that summarizes new episodes of Galaxy Balance as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Galaxy Balance podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Galaxy Balance product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Cory Smith.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Galaxy Balance release new episodes?
Galaxy Balance publishes biweekly. Our AI generates a summary within hours of each new episode.
What topics does Galaxy Balance cover?
Galaxy Balance covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Galaxy Balance summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.